D. Western Therapeutics Institute, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,288.00
-826.00
-440.00
-159.00
-289.00
109.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-145.00
156.00
-115.00
-59.00
4.00
20.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-1,299.00
-586.00
-354.00
-176.00
-216.00
175.00
Cash Flow from Investing Activities
-10.00
-15.00
-139.00
-111.00
-13.00
-100.00
Cash Flow from Financing Activities
567.00
134.00
867.00
-104.00
1,004.00
-120.00
Net Cash Inflow / Outflow
-741.00
-467.00
400.00
-374.00
767.00
-43.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
28.00
17.00
-6.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of D. Western Therapeutics Institute, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-1288.709
-1718.662
430.00
25.02%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-145.497
-124.704
-21.00
-16.67%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-1299.118
-1834.577
535.00
29.19%
Cash Flow from Investing Activities
-10.005
-0.206
-10.00
-4756.80%
Cash Flow from Financing Activities
567.628
756.696
-189.00
-24.99%
Net Cash Inflow / Outflow
-741.229
-1078.232
337.00
31.26%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.266
-0.145
0.00
283.45%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -121.38% vs -65.41% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-1,299.12
-586.82
-121.38%






